SPRING CREEK CAPITAL LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 25 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SPRING CREEK CAPITAL LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q1 2022$40,000
-63.0%
200,0000.0%0.00%
-50.0%
Q4 2021$108,000
-10.0%
200,0000.0%0.00%
-33.3%
Q3 2021$120,000
-21.1%
200,0000.0%0.01%
-25.0%
Q2 2021$152,000–200,000–0.01%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q3 2021
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders